Skip to main content

Specialty business set to spur growth for Sun Pharma in next 3 yrs: Experts

Global specialty drug sales for Sun Pharma have grown by 39% YoY in FY22 to $674 million

from Companies https://ift.tt/41PmI3B
via IFTTT

Comments

Popular posts from this blog